Global Factor VIII Deficiency Treatment Market- Regional Analysis
Among all regions, North America is expected to dominate the global market over the forecast period. This is attributed to North America holding a 39.5% market share and due to the presence of major players such as Baxter, Biogen, Inc., Bayer AG, and others contributing to the development of the factor VIII deficiency treatment market in North America.
The Asia Pacific region is expected to be the second dominating region over the forecast period, due to an increase in the number of people suffering from hemophilia. For instance, according to an article published in springer nature, an open-access scientific journal, in September 2020, the number of people suffering from hemophilia each year in India is between 100,000 – 125,000
Global factor VIII deficiency treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients